Rare Blood Vessel Disease Could Have New Treatment Option

Published July 16, 2010

Rare Blood Vessel Disease Could Have New Treatment Option
WEDNESDAY, July 14 (HealthDay News) — A drug already used to treat lymphoma and rheumatoid arthritis shows promise as an option to treat rare forms of vasculitis, a disease affecting the blood vessels, according to two new studies.
Read more on HealthDay via Yahoo! News

Keryx’s perifosine gets second orphan drug status
Keryx Biopharma says FDA granted orphan drug status to perifosine as neuroblastoma treatment
Read more on Bay News 9 Tampa Bay

Glaxo sees .4 billion charge for Avandia, Paxil
GlaxoSmithKline Plc, the U.K.’s largest drug maker, expects to record a 1.57 billion-pound (.4 billion) charge in the second quarter to settle cases including claims that its Avandia diabetes treatment led to heart attacks.
Read more on Pittsburgh Post-Gazette